Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial. (Q48331707)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 January 2017

Language	Label	Description	Also known as
English	Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial.	scientific article published on 20 January 2017

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/28105731

Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomized, placebo-controlled, double-blind, crossover trial. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/28105731

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Bernt J von Scholten

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Frederik Persson

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jesper Eugen-Olsen

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Signe Rosenlund

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Tomasz Pielak

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jens Faber

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

20 January 2017

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/28105731

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

901-905

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatment.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Midregional fragment of proadrenomedullin, new-onset albuminuria, and cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-30).

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

The midregional fragment of pro-A-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25)

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31).

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Glucagon like Peptide-1 and atherosclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FDOM.12884

21 January 2018

Identifiers

10.1111/DOM.12884

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28105731%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48331707&oldid=1428285066"